In March 2025, the company announced new strategies for a direct-to-client presenting of its Wegovy weight loss drug. The company founded a fresh pharmacy, named NovoCare, which would charge buyers $499 every month for use of the drug, less than 50 percent the price of the drug by other pharmaceutical distribution networks.[fifty three]to help Grow